Skip to Content

MainStay Balanced I MBAIX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 30.02  /  −0.07 %
  • Total Assets 453.5 Mil
  • Adj. Expense Ratio
    0.820%
  • Expense Ratio 0.820%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Moderate Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 2.28%
  • Turnover 313%

USD | NAV as of Feb 28, 2024 | 1-Day Return as of Feb 28, 2024, 11:16 PM GMT+0

Morningstar’s Analysis MBAIX

Will MBAIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay Balanced I's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MBAIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

United States Treasury Notes 5%

6.10 28.2 Mil
Government

United States Treasury Notes 4.625%

4.34 20.0 Mil
Government

iShares Intermediate Govt/Crdt Bd ETF

4.15 19.2 Mil

United States Treasury Notes 4.375%

3.47 16.0 Mil
Government

United States Treasury Notes 4.375%

3.09 14.2 Mil
Government

JPMorgan Chase & Co

2.20 10.1 Mil
Financial Services

iShares Russell 1000 Value ETF

2.15 9.9 Mil

Vanguard Russell 1000 Value ETF

1.94 9.0 Mil

Johnson & Johnson

1.68 7.7 Mil
Healthcare

Merck & Co Inc

1.50 6.9 Mil
Healthcare